Dissatisfaction with NIH Grant Allocation

The Trump administration expressed dissatisfaction with the National Institutes of Health (NIH) over how grants are awarded. Discussions emerged over the weekend to potentially introduce more political influence on the distribution of these funds.

The Washington Post reported on a tense meeting at the Oval Office. Senior administration staffers debated whether NIH was funding research contrary to President Trump’s goals.

The New York Times reported that officials were drafting an executive order. This order might establish an external committee with veto power over awards not aligning with Trump’s agenda.

OMB Accusations and Defense

Russell Vought, Director of the White House Office of Management and Budget, accused NIH of funding “woke” initiatives. NIH Director Jay Bhattacharya defended the grantmaking process.

Emily Hilliard, senior press secretary for the Department of Health and Human Services (HHS), stated, “HHS remains focused on NIH’s core mission of supporting rigorous biomedical research that improves the health of the American people. We will continue to prioritize Gold Standard Science, transparency, and responsible stewardship of taxpayer dollars.”

Political Response

Senators Susan Collins (R-Maine) and Patty Murray (D-Wash.), Senate Appropriations Committee leaders, criticized the White House’s reported plans. Collins remarked, “The Office of Management and Budget (OMB) should not be involved in agency decisions on the awards of grants.” Murray stated, “NIH funding doesn’t belong to Donald Trump — it belongs to the patients and families waiting on the next medical breakthrough.”

Welcome to The Hill’s Healthcare newsletter by Nathaniel Weixel and Joseph Choi, offering weekly updates on health policy impacts from Washington.

Essential Reads

Key policy impacts on the healthcare sector:

• Sens. Collins and Murray opposed plans to increase political oversight of NIH grantmaking.
• Gov. JB Pritzker of Illinois shared that he shed 80 pounds using a GLP-1 drug, expressing its significance to him.
• The Environmental Protection Agency (EPA) initiated a drinking water quality study, checking for traces of abortion pills mifepristone and misoprostol.

Upcoming News

News events on the radar:

• The Senate Health, Education, Labor, and Pensions Committee plans a business meeting Thursday for nominations of Nicole Saphier and Timothy Westlake.
• Confirmation hearing Thursday for Heidi Overton as the next FDA Commissioner.

In Other News

Different perspectives:

NEXSTAR reports doctors in Texas seeing rising cases of chronic kidney disease of unknown origin among healthy young men.

Local and State Headlines

• New York cut free health insurance for 450,000 people this summer (Syracuse.com).
• South Dakota received $11 million NIH grant for statewide research (Dakota News Now).
• Vaccine rates fell among Washington kindergartners; K-12 figures remain stable (The Seattle Times).

Additional Health News

• Potential outcomes of Grail’s cancer detection test vote (Stat).
• Trial for easing IUD insertion pain (MedPage Today).
• Reasons behind increased alcohol consumption among older Americans (Time).